(North America, South America, and the Caribbean)
(Including Hong Kong SAR, Macau SAR, and Taiwan)
The insights provided by Next-Generation Sequencing (NGS) into the genetic variants responsible for certain diseases allow for the discovery of new drug targets and the development of targeted therapeutics. NGS technologies can be used to generate data on genomic and epigenomic modifications, and gene expression levels, each of which is crucial for the development of therapeutics targeting genetic diseases. NGS approaches can be used at multiple stages along the clinical development pipeline, from target identification to validation.
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.